Context Therapeutics Inc. (CNTX)
Nasdaq: CNTX · Pharmaceutical Preparations · Philadelphia, PA · filing with the SEC since 2021
Who owns Context Therapeutics Inc.
As filed with the SECHolders of 5% or more
4
Avidity Partners Management LP holds 8.7% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed May 12, 2026 says.
Directors and officers
10
report now, of 15 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Avidity Partners Management LP
SCHEDULE 13G/A · filed May 12, 2026 · Common Stock, par value $0.001 per share · 9.9% in Nov 14, 2025
Deep Track Capital, LP
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.001 par value per share
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed May 8, 2026 · Common Stock, par value $0.001 per share · 5.2% in Feb 3, 2026
Blackrock, Inc.
SCHEDULE 13G · filed Jul 27, 2026 · Common Stock
Franklin Resources, Inc.
SCHEDULE 13G/A · filed May 9, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.3% in Jan 27, 2025
Octagon Capital Advisors LP
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock, $0.001 par value · reported falling below 5%, from 5.7% in May 14, 2026
Blue Owl Capital Holdings LP
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.54% in May 14, 2026
Great Point Partners, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock · reported falling below 5%, from 5.1% in Feb 17, 2026
Martin Lehr
SCHEDULE 13G/A · filed Feb 12, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
MPM BioImpact LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 11.6% in Feb 17, 2026
Opaleye Management Inc.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
What CNTX reports owning in othersstakes of 5% or more, and other ties
Context Therapeutics Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.